3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Head and Neck Neoplasms
19
Squamous Cell Carcinoma of Head and Neck
11
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
6
Neoplasms
4
Melanoma
4
Laryngeal Diseases
4
Carcinoma
3
Stomach Neoplasms
2
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Neoplasms, Squamous Cell
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Hypopharyngeal Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Breast Neoplasms
2
Thyroid Neoplasms
1
Thyroid Diseases
1
Thyroid Carcinoma, Anaplastic
1
Thoracic Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Recurrence
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Interventions
Iodine-131
21
lenvatinib
17
Magnetic Resonance Spectroscopy
17
trametinib
13
Sorafenib
13
Thyrotropin Alfa
12
pembrolizumab
11
dabrafenib
11
Thyroidectomy
10
Surgical Procedures, Operative
10
Thyroxine
9
Paclitaxel
9
vandetanib
8
selpercatinib
8
Sunitinib
7
Nivolumab
7
Fluorodeoxyglucose F18
7
cabozantinib
6
anlotinib
6
Everolimus
6
Biopsy
6
pazopanib
5
Vemurafenib
5
Triiodothyronine
5
Specimen Handling
5
Saline Solution
5
Radiotherapy
5
Radiofrequency Ablation
5
Iodine-124
5
Cyclophosphamide
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Pemetrexed
×
Head & Neck
×
Clear all
NCT00786552
2011-01-20
Panthera
University Hospital Schleswig-Holstein
Phase 2
Unknown
47 enrolled